Literature DB >> 20413004

The role of the China Experts Advisory Committee on Immunization Program.

Jingshan Zheng1, Yuqing Zhou, Huaqing Wang, Xiaofeng Liang.   

Abstract

The Experts Advisory Committee on Immunization Program (EACIP) of China was founded in 1982, and currently consists of 33 experts in immunization and related fields, selected by the Ministry of Health, to provide advice and guidance on the control of vaccine-preventable diseases. The main tasks of the EACIP are to advise on the national immunization schedule, to participate in the drafting and review of technical documents, and to participate in field supervision and staff training. In 2007, the EACIP used evidence-based methods to formulate a revised national immunization schedule. The EACIP has played and is playing an increasingly important role in guiding immunization policy in China.
Copyright © 2010. Published by Elsevier Ltd.

Mesh:

Year:  2010        PMID: 20413004     DOI: 10.1016/j.vaccine.2010.02.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China.

Authors:  Yu Hu; Shuying Luo; Xuewen Tang; Linqiao Lou; Yaping Chen; Jing Guo
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The epidemiology of measles in Tianjin, China, 2005-2014.

Authors:  Xiexiu Wang; Matthew L Boulton; JoLynn P Montgomery; Bradley Carlson; Ying Zhang; Brenda Gillespie; Abram L Wagner; Yaxing Ding; Xiaoyan Luo; Tian Hong
Journal:  Vaccine       Date:  2015-10-17       Impact factor: 3.641

3.  A population profile of measles susceptibility in Tianjin, China.

Authors:  Matthew L Boulton; Xiexiu Wang; Ying Zhang; JoLynn P Montgomery; Abram L Wagner; Bradley F Carlson; Yaxing Ding; Xiaoyan Li; Brenda Gillespie; Xu Su
Journal:  Vaccine       Date:  2016-05-03       Impact factor: 3.641

4.  Key genes and pathways in measles and their interaction with environmental chemicals.

Authors:  Rongqiang Zhang; Hualin Jiang; Fengying Li; Ning Su; Yi Ding; Xiang Mao; Dan Ren; Jing Wang
Journal:  Exp Ther Med       Date:  2018-04-11       Impact factor: 2.447

5.  Household survey analysis of the impact of comprehensive strategies to improve the expanded programme on immunisation at the county level in western China, 2006-2010.

Authors:  Yuqing Zhou; Yi Xing; Xiaofeng Liang; Chenyan Yue; Xu Zhu; David Hipgrave
Journal:  BMJ Open       Date:  2016-03-10       Impact factor: 2.692

6.  The impact of supplementary immunization activities on the epidemiology of measles in Tianjin, China.

Authors:  Abram L Wagner; Ying Zhang; Bhramar Mukherjee; Yaxing Ding; Eden V Wells; Matthew L Boulton
Journal:  Int J Infect Dis       Date:  2016-03-10       Impact factor: 3.623

7.  Preferences for vaccination program attributes among parents of young infants in Shanghai, China.

Authors:  Zhuoying Huang; Abram L Wagner; Muzi Lin; Xiaodong Sun; Brian J Zikmund-Fisher; Matthew L Boulton; Jia Ren; Lisa A Prosser
Journal:  Hum Vaccin Immunother       Date:  2020-01-24       Impact factor: 3.452

8.  Measles Antibodies in Mother-Infant Dyads in Tianjin, China.

Authors:  Matthew L Boulton; Xiexiu Wang; Abram L Wagner; Ying Zhang; Bradley F Carlson; Brenda W Gillespie; Yaxing Ding
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

9.  Using the Immunization Information System to determine vaccination coverage rates among children aged 1-7 years: a report from Zhejiang Province, China.

Authors:  Qian Li; Yu Hu; Yanpeng Zhong; Yaping Chen; Xuewen Tang; Jing Guo; Lingzhi Shen
Journal:  Int J Environ Res Public Health       Date:  2014-03-05       Impact factor: 3.390

10.  Effects of the health insurance coverage extension on the use of outpatient services among small children in rural China.

Authors:  Nobuo Kawazoe; Guoxiang Liu; Chifa Chiang; Yan Zhang; Atsuko Aoyama
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.